RPS6KB1 and hepatocellular carcinoma: In HCC, the activation of FXR by GW4064 inhibits HCC growth through inhibiting the mTOR-S6K pathway, while it enhances (TGF)-β-induced EMT in HCC cells, indicating its dual role in HCC development [86,197].